HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frequent progesterone receptor immunoreactivity in tuberous sclerosis-associated renal angiomyolipomas.

Abstract
Angiomyolipomas can occur sporadically or in association with tuberous sclerosis complex (TSC). TSC is an autosomal dominant disorder characterized by seizures, mental retardation, and benign tumors of the brain, heart, kidney, and skin. Angiomyolipomas are more common in women than in men, suggesting a possible hormonal influence on tumor growth. In this study, 35 angiomyolipomas from 23 patients were immunostained with antibodies to estrogen receptor (ER) and progesterone receptor (PR). Eleven angiomyolipomas (31%) contained clusters of PR-immunoreactive smooth muscle cells. None contained ER-immunoreactive cells. Of the 21 tumors from patients with TSC, 11 (48%) were PR immunoreactive. All of the PR-immunoreactive angiomyolipomas were from women younger than 50 years of age, and all except one of these women had TSC. This study suggests that hormonal factors play a role in the pathogenesis of TSC-associated angiomyolipomas.
AuthorsE P Henske, X Ao, M P Short, R Greenberg, H P Neumann, D J Kwiatkowski, I Russo
JournalModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc (Mod Pathol) Vol. 11 Issue 7 Pg. 665-8 (Jul 1998) ISSN: 0893-3952 [Print] United States
PMID9688188 (Publication Type: Journal Article)
Chemical References
  • Receptors, Estrogen
  • Receptors, Progesterone
Topics
  • Adult
  • Age Distribution
  • Angiomyolipoma (metabolism)
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Kidney Neoplasms (metabolism)
  • Male
  • Middle Aged
  • Receptors, Estrogen (metabolism)
  • Receptors, Progesterone (metabolism)
  • Tuberous Sclerosis (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: